Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
FIT-screening: een of twee samples?
jul 2019 | Maag-darm-leveroncologie